Sinomab Bio hits 52-week low

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Sinomab Bio (3681.HK) fell nearly 5% in Hong Kong trading to HK$0.9550, hitting a 52-week low intraday.

The stock is down 10.75% over the past ten sessions and down 28.73% year to date. It sits 56.39% below its 52-week high of HK$2.190. Volume was 0.31 times its average.

The Hang Seng Index is down 3.48% over the past five sessions and down 7.80% year to date.

The biotechnology industry index fell 3.0% over the same period, in line with the stock's move.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.